Article
Case Report: Sirolimus as management strategy for thrombocytopenia related to ARPC1B deficiency.
Frontiers in immunology - 1 Jan 2026
Dell'Orso Gianluca, Guardigni Martina, Palmisani Elena, Drago Enrico, Penco Federica, Prigione Ignazia, Conteduca Giuseppina, Baselli Lucia Augusta, Rossano Martina, Lemmi Damiano, Giarratana Maria Carla, Mariani Eugenia, Arcuri Luca, Volpi Stefano, Miano Maurizio
Abstract excerpt
Biallelic mutations in ARPC1B gene are responsible for an inborn error of immunity (IEI) characterized by thrombocytopenia and combined immunodeficiency with heterogeneous immune-dysregulatory features. Sirolimus is a mammalian target of rapamycin (mTOR) inhibitor, which is successfully used in patients affected by primary or secondary autoimmune cytopenias. We report the case of a patient suffering from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
